Infla-650: Infla-650 Herbal Dietary Supplement Capsules — FDA announcement Jul 16, 2024

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Jul 16, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Infla-650 Herbal Dietary Supplement Capsules
Reason
Tainted with the drug ingredients: acetaminophen, diclofenac and phenylbutazone
Classification
Not supplied
Recalling firm
Guru Inc.
Quantity
Not supplied
Agency-reported status
Company recall announcement
Source record identifier
7ed9a44846313b22

Open the official record

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityFOR IMMEDIATE RELEASE – 07/16/2024 – Lilburn, GA, GURU INC. is voluntarily recalling Infla-650 Herbal Dietary Supplement Capsules, Lot No. IN-032, 700 mg to the consumer/user level. Infla-650 capsules has been found to be tainted with acetaminophen, diclofenac and phenylbutazone, which are not listed on the label. Products containing acetaminophen, diclofenac and phenylbutazone cannot be marketed as dietary supplements. Infla-650 Herbal Dietary Supplement Capsules is an unapproved new drug for which safety and efficacy have not been established and, therefore, subject to recall.; The tainted product is marketed as an herbal dietary supplement for pain relief and is packaged in stand-up pouches of 60 capsules. The affected Infla-650 product, include the following Lot No. IN-032 and expiration date: NOV. 2027. The product can be identified by silver standup pouch with green in white color theme label. Infla-650 was shipped between 03/04/2024-06/24/2024 nationwide to retailers and on internet via https://www.nutraherbusa.com/ and https://www.nutra650.com/.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

The tainted product is marketed as an herbal dietary supplement for pain relief and is packaged in stand-up pouches of 60 capsules. The affected Infla-650 product, include the following Lot No. IN-032 and expiration date: NOV. 2027. The product can be identified by silver standup pouch with green in white color theme label. Infla-650 was shipped between 03/04/2024-06/24/2024 nationwide to retailers and on internet via https://www.nutraherbusa.com/ and https://www.nutra650.com/.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Fda listing date
Jul 16, 2024
Company announcement date
Jul 16, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records